Evaluation of the 9-item patient health questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis

Postgraduate Medicine

Volumn 124, Issue 5, 2012, Pages 69-77

  Sjonnesen, Kirsten ^a   Berzins, Sandy ^a   Fiest, Kirsten M ^a   Bulloch, Andrew G M ^a   Metz, Luanne M ^a   Thombs, Brett D ^b   Patten, Scott B ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Assessment instrument; Depressive disorders; Multiple sclerosis

Indexed keywords

ADULT; AGE; AGED; ALGORITHM; ARTICLE; ATTENTION; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; FATIGUE; FEMALE; GENDER; GUILT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATIENT HEALTH QUESTIONNAIRE; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT; COMORBIDITY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; STATISTICAL MODEL; VALIDATION STUDY;

ALGORITHMS; COMORBIDITY; DEPRESSION; DEPRESSIVE DISORDER; HUMANS; LOGISTIC MODELS; MULTIPLE SCLEROSIS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES;

EID: 84873260523     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2012.09.2595     Document Type: Article

References (33)

1. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648): 502-517.
2. Multiple Sclerosis Society of Canada website. Estimated number of Canadians with multiple sclerosis re-examined. http://mssociety.ca/ en/releases/NR_May06.htm. Accessed July 13, 2012.
3. National Multiple Sclerosis Society website. Epidemiology of MS. http://www.nationalmssociety.org/about-multiple-sclerosis/what-we-know-about-ms/who-gets-ms/epidemiology-of-ms/index.aspx. Accessed July 13, 2012.
4. Patten SB, Beck CA, Williams JV, Barbui C, Metz LM. Major depression in multiple sclerosis: a population-based perspective. Neurology. 2003;61(11):1524-1527.
5. Sadovnik AD, Remick RA, Allen J, et al. Depression and multiple sclerosis. Neurology. 1996;46(3):628-632.
6. Minden SL, Orav J, Reich P. Depression in multiple sclerosis. Gen Hosp Psychiatry. 1987;9(6):426-434.
7. Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol. 1997;54(5):531-533.
8. Shnek ZM, Foley FW, LaRocca NG, et al. Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury. Ann Behav Med. 1997;19(3):287-294.
9. Stenager EN, Stenager E, Koch-Henriksen N, et al. Suicide and multiple sclerosis: an epidemiological investigation. J Neurol Neurosurg Psychiatry. 1992;55(7):542-545.
10. Benedict RH, Wahlig E, Bakshi R, et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci. 2005;231(1-2):29-34.
11. Lobentanz IS, Asenbaum S, Vass K, et al. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand. 2004;110(1):6-13.
12. Mohr DC, Goodkin DE. Treatment of depression in multiple sclerosis: review and meta-analysis. Clin Psychol Sci Prac. 1999;6(1):1-9.
13. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9): 606-613.
14. Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J Gen Intern Med. 2007;22(11): 1596-1602.
15. Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a metaanalysis. CMAJ. 2012;184(3):E191-E196.
16. Wittkampf KA, Naeije L, Schene AH, Huyser J, van Weert HC. Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review. Gen Hosp Psychiatry. 2007;29(5): 388-395.
17. American Psychiatric Association. Mood disorders. In: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000: 345-428.
18. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol. 1988;45(4):435-437.
19. Bobholz JA, Rao SM. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol. 2003;16(3): 283-288.
20. Mohr DC, Goodkin DE, Likosky W, Beutler L, Gatto N, Langan MK. Identification of Beck Depression Inventory items related to multiple sclerosis. J Behav Med. 1997;20(4):407-414.
21. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology. 1991;41(5):685-691.
22. Guimarães J, Sá MJ. Cognitive dysfunction in multiple sclerosis. Front Neurol. 2012;3:74
23. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci. 1994;21(1):9-14.
24. Patten SB, Schopflocher D. Longitudinal epidemiology of major depression as assessed by the Brief Patient Health Questionnaire (PHQ-9). Compr Psychiatry. 2009;50(1):26-33.
25. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. J Am Med Assoc. 1999;282(18):1737-1744.
26. Cannon DS, Tiffany ST, Coon H, Scholand MB, McMahon WM, Leppert MF The PHQ-9 as a brief assessment of lifetime major depression. Psychol Assess. 2007;19(2):247-251.
27. Feinstein A, Feinstein K. Depression associated with multiple sclerosis. Looking beyond diagnosis to symptom expression. J Affect Disord. 2001;66(2-3):193-198.
28. Stata [computer program]. Version 11.2. College Station, TX: StataCorp LP; 2009.
29. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174.
30. Streiner DL, Norman GR. Selecting the items. Streiner DL, Norman GR, eds. Health Measurement Scales: A Practical Guide to Their Development and Use. 4th ed. New York, NY: Oxford University Press; 2008:77-102.
31. Nyenhuis DL, Rao SM, Zajecka JM, Luchetta T, Bernardin L, Garron DC. Mood disturbance versus other symptoms of depression in multiple sclerosis. J Int Neuropsychol Soc. 1995;1(3):291-296.
32. Kowal J, Wilson KG, McWilliams LA, Péloquin K, Duong D. Self-perceived burden in chronic pain: relevance, prevalence, and predictors. Pain. 2012;153(8):1735-1741.
33. Leavens A, Patten SB, Hudson M, Baron M, Thombs BD; for the Canadian Scleroderma Research Group. Influence of somatic symptoms on Patient Health Questionnaire-9 depression scores among patients with systemic sclerosis compared to healthy general population sample. Arthritis Care Res (Hoboken). 2012;64(8):1195-1201.